Oticon Zeal vs Otofonix Groove

The Oticon Zeal is a premium prescription hearing aid in the invisible-in-ear style, carrying an A grade with a SoundScore of 4.7/5 in our lab testing. Priced at $4,798, it ranks #6 among 39 prescription hearing aids tested, placing it in the top 13% of its category. Speech performance is where the Zeal truly excels. Our testing measured an excellent 4.9/5 for speech in quiet—1.48 points above the category average—making it one of the strongest performers for everyday conversations. Speech in noise also scores a solid 3.0/5, sitting 0.93 points above the category average of 2.11/5, indicating reliable performance in moderately challenging listening environments. Music streaming quality registers at a solid 3.3/5, which is 0.54 points above the category average. However, the Zeal shows some limitations in other areas. Own-voice comfort scores a mixed 2.0/5, falling 0.70 points below the category average—something to consider if own-voice naturalness is a priority. Feedback handling measures at 3.3/5, which is solid in absolute terms but sits 1.42 points below the category average of 4.72/5. The Oticon Zeal is best suited for wearers who prioritize exceptional speech clarity and want a discreet, invisible-in-ear form factor. Those especially sensitive to feedback or own-voice effects may want to discuss these trade-offs with their hearing care provider during fitting.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.